BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
67 hedge funds and large institutions have $64.4M invested in BioDelivery Sciences International, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 17 reducing their positions, and 7 closing their positions.
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
53% more capital invested
Capital invested by funds: $42.1M → $64.4M (+$22.3M)
35% more call options, than puts
Call options by funds: $463K | Put options by funds: $344K
6% more funds holding
Funds holding: 63 → 67 (+4)
6% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
+$1.64M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$1.34M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.02M |
| 4 |
Renaissance Technologies
New York
|
+$713K |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
+$710K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.43M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.28M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.01M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$657K |
| 5 |
BC
Broadfin Capital
New York
|
-$584K |
BDSI Hedge Fund Activity: Q2 2017 in Review
67 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2017, worth a combined $64.4M — up 53% from $42.1M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new BDSI positions and 7 closed out — a net gain of 5 holders — while 18 added to existing stakes and 17 trimmed.
The largest buyer was William Blair & Company, adding an estimated $1.64M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $1.43M sold.
- 67 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2017, up from 63 in Q1 2017.
- Funds reported $64.4M of BioDelivery Sciences International, Inc. stock for Q2 2017, up 53% quarter-over-quarter.
- 12 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2017 and 7 closed out, a net change of +5 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q2 2017 was William Blair & Company, an estimated $1.64M added.
- The largest BioDelivery Sciences International, Inc. seller in Q2 2017 was Adage Capital Partners, an estimated $1.43M sold.
Based on aggregated 13F filings for Q2 2017.